Biophysical characterisation of the structure of a SARS-CoV-2 self-amplifying—RNA (saRNA) vaccine

Myatt D, Wharram L, Graham C, Liddell J, Branton H, Pizzey C, Cowieson N, Rambo R, Shattock R, Biology Methods and Protocols (2023) DOI

SASDPJ3 – IMP-1 saRNA encoding NSP1-4 of VEEV and the spike glycoprotein of SARS-CoV-2

IMP-1 saRNA
MWexperimental 3270 kDa
MWexpected 3720 kDa
VPorod 6265 nm3
log I(s) 3.77×10-1 3.77×10-2 3.77×10-3 3.77×10-4
IMP-1 saRNA small angle scattering data  s, nm-1
ln I(s)
IMP-1 saRNA Guinier plot ln 3.78×10-1 Rg: 23.8 nm 0 (23.8 nm)-2 s2
(sRg)2I(s)/I(0)
IMP-1 saRNA Kratky plot 1.104 0 3 sRg
p(r)
IMP-1 saRNA pair distance distribution function Rg: 27.1 nm 0 Dmax: 85.9 nm

Data validation


There are no models related to this curve.

Synchrotron SAXS data from solutions of IMP-1 saRNA encoding NSP1-4 of VEEV and the spike glycoprotein of SARS-CoV-2 in 5 mM sodium citrate formulation buffer, pH 6.4 were collected on the B21 beam line at the Diamond Light Source (Didcot, UK) using a Eiger 4M detector at a sample-detector distance of 4.0 m and at a wavelength of λ = 0.1 nm (I(s) vs s, where s = 4πsinθ/λ, and 2θ is the scattering angle). In-line size-exclusion chromatography (SEC) SAS was employed. The SEC parameters were as follows: A 35.00 μl sample at 2.0 mg/ml was injected at a 0.16 ml/min flow rate onto a Shodex KW400 series column at 20°C. 640 successive 3 second frames were collected. The data were normalized to the intensity of the transmitted beam and radially averaged; the scattering of the solvent-blank was subtracted.

IMP-1 saRNA (IMP-1)
Mol. type   RNA
Olig. state   Monomer
Mon. MW   3720.5 kDa
Sequence   FASTA